Tumor Volume Estimation and Quasi-Continuous Administration for Most Effective Bevacizumab Therapy

Model-based angiogenic inhibition of tumor growth using modern robust control method

(2014) Levente Kovács et al.   COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE

Potential applications of nanotechnology for the diagnosis and treatment of pancreatic cancer

(2014) Joshua McCarroll et al.   Frontiers in Physiology

The artificial pancreas: a digital-age treatment for diabetes

(2014) Claudio Cobelli et al.   Lancet Diabetes & Endocrinology

The Impact of Bevacizumab (Avastin) on Survival in Metastatic Solid Tumors - A Meta-Analysis and Systematic Review

(2013) Limor Amit et al.   PLoS One

Vascular Normalization as a Therapeutic Strategy for Malignant and Nonmalignant Disease

(2013) S. Goel et al.   Cold Spring Harbor Perspectives in Medicine

Evidence-based role of bevacizumab in non-small cell lung cancer

(2012) E. E. Vokes et al.   ANNALS OF ONCOLOGY

Systematic review and meta-analysis of randomised, phase II/III trials adding bevacizumab to platinum-based chemotherapy as first-line treatment in patients with advanced non-small-cell lung cancer

(2012) J.-C. Soria et al.   ANNALS OF ONCOLOGY

ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making

(2012) H. J. Schmoll et al.   ANNALS OF ONCOLOGY

Randomized, Double-Blind, Placebo-Controlled Phase III Trial Comparing Docetaxel and Prednisone With or Without Bevacizumab in Men With Metastatic Castration-Resistant Prostate Cancer: CALGB 90401

(2012) William Kevin Kelly et al.   JOURNAL OF CLINICAL ONCOLOGY

Avastin loses breast cancer indication

(2012) Karen Carey   NATURE BIOTECHNOLOGY

Fighting Fire with Fire: Rekindling the Bevacizumab Debate

(2012) Alberto J. Montero et al.   NEW ENGLAND JOURNAL OF MEDICINE

Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer

(2012) Harry D. Bear et al.   NEW ENGLAND JOURNAL OF MEDICINE

Neoadjuvant Chemotherapy and Bevacizumab for HER2-Negative Breast Cancer

(2012) Gunter von Minckwitz et al.   NEW ENGLAND JOURNAL OF MEDICINE

Bevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study

(2011) Atsushi Ohtsu et al.   JOURNAL OF CLINICAL ONCOLOGY

BEAM: A Randomized Phase II Study Evaluating the Activity of Bevacizumab in Combination With Carboplatin Plus Paclitaxel in Patients With Previously Untreated Advanced Melanoma

(2011) Kevin B. Kim et al.   JOURNAL OF CLINICAL ONCOLOGY

Induced L2-norm minimization of glucose–insulin system for Type I diabetic patients

(2010) Levente Kovács et al.   COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE

Capecitabine, Bevacizumab, and Mitomycin in First-Line Treatment of Metastatic Colorectal Cancer: Results of the Australasian Gastrointestinal Trials Group Randomized Phase III MAX Study

(2010) Niall C. Tebbutt et al.   JOURNAL OF CLINICAL ONCOLOGY

Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303)

(2010) Hedy Lee Kindler et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase III Trial of Bevacizumab Plus Interferon Alfa Versus Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: Final Results of CALGB 90206

(2010) Brian I. Rini et al.   JOURNAL OF CLINICAL ONCOLOGY

Bevacizumab (Avastin)

(2009) S.K. Mukherji   AMERICAN JOURNAL OF NEURORADIOLOGY

Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma

(2009) Henry S. Friedman et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase II Trial of Bevacizumab in the Treatment of Persistent or Recurrent Squamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group Study

(2009) Bradley J. Monk et al.   JOURNAL OF CLINICAL ONCOLOGY

BEVACIZUMAB (AVASTIN) DOES NOT HARM RETINAL FUNCTION AFTER INTRAVITREAL INJECTION AS SHOWN BY ELECTRORETINOGRAPHY IN ADULT MICE

(2009) PETER HEIDUSCHKA et al.   RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES

Antiangiogenic drugs in ovarian cancer

(2008) G C Kumaran et al.   BRITISH JOURNAL OF CANCER

Drug Insight: antiangiogenic therapies for gastrointestinal cancers—focus on monoclonal antibodies

(2008) Anke Reinacher-Schick et al.   Nature clinical practice. Gastroenterology & hepatology